Literature DB >> 12351936

Ethanol-induced modulation of inducible nitric-oxide synthase activity in human A172 astrocytoma cells.

Randall L Davis1, Janet Dertien, Peter J Syapin.   

Abstract

BACKGROUND: Glial cells are critical in the functioning of the central nervous system (CNS), including responsiveness to injury and immunocompetence. The immune and inflammatory response involves the inducible form of nitric-oxide synthase (iNOS), and subsequent nitric oxide (NO) production. Previously, we have demonstrated that ethanol inhibits cytokine-induced iNOS expression and activity in rat glial cells. Evidence of ethanol-induced effects on iNOS in human glial cells is nonexistent. Herein, the conditions necessary for significant iNOS induction in human A172 astrocytoma cells have been characterized, and subsequently, the effects of ethanol on iNOS expression have been investigated.
METHODS: A172 cells were analyzed immunohistochemically for the astrocyte markers, glial fibrillary acidic protein (GFAP) and S-100beta. The ability of A172 cells to express iNOS was assessed by stimulating cells with interferon-gamma (IFNgamma), tumor necrosis factor-alpha (TNFalpha), interleukin-1beta (IL-1beta), bacterial lipopolysaccharide (LPS), L-arginine, and tetrahydrobiopterin (BH4) in various combinations. Following stimulation, iNOS induction was monitored via measurement of nitrite production and in vitro iNOS enzyme activity. Time-course (6-24 hr) studies assessed the effects of ethanol (50-200 mM) on iNOS induction.
RESULTS: Immunohistochemistry analysis confirmed that A172 cells were phenotypically, astrocytic. Induction of nitrite production by a cytomix [IFNgamma (100 ng/ml) + TNFalpha (30 ng/ml) + IL-1beta (5 ng/ml)] was differentially enhanced by exposure to supplemental factors including LPS, L-arginine, and BH4. Nitrite production was greatest over the initial 24 hr of stimulation with iNOS enzyme activity peaking at 12 hr. Acute (6-24 hr) exposure of activated cells to 50 mM ethanol enhanced iNOS activity recovered from the cytosol, whereas 200 mM ethanol decreased it. Ethanol had no direct effect on the catalytic activity of the enzyme.
CONCLUSIONS: The present study is the first published report of ethanol-induced modulation of iNOS expression in human glial cells. The data suggest that ethanol is influencing iNOS enzyme levels most profoundly. Altered astrocyte function may be a point of ethanol-induced perturbation in CNS immune function. These findings should lend insight into the role of ethanol on human CNS immunity and brain injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12351936     DOI: 10.1097/01.ALC.0000030841.92766.80

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  18 in total

1.  HIV-1 Tat-mediated induction of platelet-derived growth factor in astrocytes: role of early growth response gene 1.

Authors:  Crystal Bethel-Brown; Honghong Yao; Shannon Callen; Young Han Lee; Prasanta K Dash; Anil Kumar; Shilpa Buch
Journal:  J Immunol       Date:  2011-03-02       Impact factor: 5.422

2.  The opioid antagonist, β-funaltrexamine, inhibits NF-κB signaling and chemokine expression in human astrocytes and in mice.

Authors:  Randall L Davis; Subhas Das; J Thomas Curtis; Craig W Stevens
Journal:  Eur J Pharmacol       Date:  2015-05-22       Impact factor: 4.432

3.  Chronic inorganic mercury exposure induces sex-specific changes in central TNFα expression: importance in autism?

Authors:  J Thomas Curtis; Yue Chen; Daniel J Buck; Randall L Davis
Journal:  Neurosci Lett       Date:  2011-08-31       Impact factor: 3.046

4.  Temporal and Site-Specific Changes in Central Neuroimmune Factors During Rapid Weight Gain After Ovariectomy in Rats.

Authors:  Kathleen S Curtis; Kelly McCracken; Enith Espinosa; Johnson Ong; Daniel J Buck; Randall L Davis
Journal:  Neurochem Res       Date:  2018-07-20       Impact factor: 3.996

5.  The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cells.

Authors:  Randall L Davis; Daniel J Buck; Neda Saffarian; Craig W Stevens
Journal:  J Neuroimmunol       Date:  2007-05-01       Impact factor: 3.478

6.  Proinflammatory cytokines and HIV-1 synergistically enhance CXCL10 expression in human astrocytes.

Authors:  Rachel Williams; Navneet K Dhillon; Sonia T Hegde; Honghong Yao; Fuwang Peng; Shannon Callen; Yahia Chebloune; Randall L Davis; Shilpa J Buch
Journal:  Glia       Date:  2009-05       Impact factor: 7.452

7.  Cooperative induction of CXCL10 involves NADPH oxidase: Implications for HIV dementia.

Authors:  Rachel Williams; Honghong Yao; Fuwang Peng; Yanjing Yang; Crystal Bethel-Brown; Shilpa Buch
Journal:  Glia       Date:  2010-04       Impact factor: 7.452

Review 8.  Ethanol metabolism and effects: nitric oxide and its interaction.

Authors:  Xin-Sheng Deng; Richard A Deitrich
Journal:  Curr Clin Pharmacol       Date:  2007-05

9.  Beta-funaltrexamine inhibits inducible nitric-oxide synthase expression in human astroglial cells.

Authors:  Randall L Davis; Daniel J Buck; Neda Saffarian; Shekher Mohan; Udaya DeSilva; Samodha C Fernando; Craig W Stevens
Journal:  J Neuroimmune Pharmacol       Date:  2008-02-16       Impact factor: 4.147

10.  Β-funaltrexamine inhibits chemokine (CXCL10) expression in normal human astrocytes.

Authors:  Randall L Davis; Subhas Das; Daniel J Buck; Craig W Stevens
Journal:  Neurochem Int       Date:  2013-01-31       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.